RXI PHARMACEUTICALS CORP NEW's ticker is RXIIXXXX and the CUSIP is 74979C501. A total of 19 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 397,371 | $284,000 | 0.02% |
| Hudson Bay Capital Management LP | 428,812 | $306,000 | 0.00% |
| FNY Partners Fund LP | 179 | $0 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 38 | $0 | 0.00% |
| Virtu KCG Holdings LLC | 27,689 | $20,000 | 0.00% |
| IFP Advisors, Inc | 1 | $0 | 0.00% |
| Advisor Group, Inc. | 163 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,096 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 26,638 | $19,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,396 | $0 | 0.00% |